Application of high-flow nasal oxygen during anesthesia induction for frame-based stereoelectroencephalography: a randomized controlled non-inferiority trial

在基于帧的立体脑电图麻醉诱导期间应用高流量鼻氧:一项随机对照非劣效性试验

阅读:1

Abstract

BACKGROUND: High-flow nasal oxygen (HFNO) is increasingly used for preoxygenation and apneic oxygenation; however, its efficacy during anesthesia induction for frame-based stereoelectroencephalography (SEEG) remains uncertain. This study evaluated whether HFNO is non-inferior to facemask ventilation in maintaining oxygenation during anesthesia induction for frame-based SEEG. METHODS: In this randomized, controlled, non-inferiority trial, adult patients with refractory epilepsy undergoing frame-based SEEG were randomized to either the HFNO or facemask group. The primary endpoint was the lowest peripheral oxygen saturation (SpO(2)). Secondary endpoints included arterial blood gas analyses, hemodynamic measures, airway adjuncts use, first-pass intubation success (FPS), time to secure the airway, anesthesiologist satisfaction, patient comfort, and perioperative complications. RESULTS: Among 46 patients, the median (interquartile range [IQR]) lowest SpO(2) was 98 (97-99) % in the HFNO group vs. 96 (95-98) % in the facemask group, with a median difference of 1% (95 confidence interval [CI], 0-2%), confirming non-inferiority within a 2% margin. Post-intubation partial pressure of oxygen (PaO(2)) was significantly higher in the HFNO group than that in the facemask group, with median (IQR) of 437.8 (411.1-474.4) mmHg and 400.6 (365.6-435.2) mmHg, respectively. HFNO reduced the airway adjuncts use (0/23 vs. 6/23 patients; p = 0.022), shortened the time to secure the airway (p = 0.015), and improved anesthesiologist satisfaction and patient comfort (both p < 0.0001). Hemodynamic parameters and FPS were similar between groups. CONCLUSION: HFNO is non-inferior to facemask ventilation in maintaining oxygenation during anesthesia induction for frame-based SEEG. Moreover, HFNO reduces the need for airway adjuncts, shortens airway securement time, and enhances both patient and anesthesiologist satisfaction. TRIAL REGISTRATION: This study was registered in the Chinese Clinical Trial Registry (ChiCTR2100044239; first registration date: March 12, 2021; https://www.chictr.org.cn/showproj.html?proj=119780 ).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。